Table 1.
Experiment 1: mean exploration times ± SEM during the sample or test phase after infusions of vehicle or CNQX into the mPFC or PRH in the object-in-place task (5 min delay)
| Drug/side | mPFC |
PRH |
Unilateral mPFC and PRH |
|||
|---|---|---|---|---|---|---|
| Expl. in sample phase (s) | Expl. in test phase (s) | Expl. in sample phase (s) | Expl. in test phase (s) | Expl. in sample phase (s) | Expl. in test phase (s) | |
| CNQX | 62.5 ± 2.1 | 23.5 ± 2.1 | 57.9 ± 3.9 | 18.7 ± 2.1 | ||
| Veh | 57.3 ± 3.0 | 14.2 ± 1.5 | 60.7 ± 3.6 | 18.2 ± 1.5 | ||
| Ipsi | 50.7 ± 4.3 | 18.8 ± 3.05 | ||||
| Contra | 48.8 ± 5.3 | 17.9 ± 1.60 | ||||
Expl., Exploration; Veh, vehicle.